Rowland, A
Dias, M M
Wiese, M D
Kichenadasse, G
McKinnon, R A
Karapetis, C S
Sorich, M J
Article History
Revised: 17 April 2015
Accepted: 22 April 2015
First Online: 19 May 2015
Competing interests
: CSK is an advisory board member for Amgen and Merck Serono. GK is an honorary advisory board member for Bayer. The other authors declare no conflict of interest.